Lipidforandringer Hos olanzapinbehandlede patienter i placebo- kontrollerede kliniske undersøgelser, er der set uønskede forandringer i lipidniveauer (se pkt.
Lipid alterations Undesirable alterations in lipids have been observed in olanzapine-treated patients in placebo- controlled clinical trials (see section 4.8).